These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30816328)

  • 1. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
    Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
    Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
    Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
    Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
    Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
    Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
    Tsuchiya KD; Davis B; Gardner RA
    Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
    Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
    Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
    Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
    Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia.
    Harrison CJ; Schwab C
    Eur J Med Genet; 2016 Mar; 59(3):162-5. PubMed ID: 26836400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
    Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
    Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
    J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
    Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
    Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis.
    Trinquand A; Betts DR; Harte S; Sills A; Rooney S; Barrett N; Storey L; Malone A; O'Marcaigh A; Smith OP
    Leuk Lymphoma; 2024 Feb; 65(2):279-282. PubMed ID: 37909291
    [No Abstract]   [Full Text] [Related]  

  • 12. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
    Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
    J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of heterozygosity on chromosome 12q in non-small-cell lung carcinomas.
    Ding XJ; Liu MX; Ao L; Liang YR; Cao Y
    Virchows Arch; 2011 May; 458(5):561-9. PubMed ID: 21279520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.
    Harrison CJ
    Blood; 2015 Feb; 125(9):1383-6. PubMed ID: 25608562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
    Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG
    Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
    Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
    Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
    Sinclair PB; Blair HH; Ryan SL; Buechler L; Cheng J; Clayton J; Hanna R; Hollern S; Hawking Z; Bashton M; Schwab CJ; Jones L; Russell LJ; Marr H; Carey P; Halsey C; Heidenreich O; Moorman AV; Harrison CJ
    Haematologica; 2018 Apr; 103(4):634-644. PubMed ID: 29449437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the RAS pathway in iAMP21-ALL.
    Ryan SL; Matheson E; Grossmann V; Sinclair P; Bashton M; Schwab C; Towers W; Partington M; Elliott A; Minto L; Richardson S; Rahman T; Keavney B; Skinner R; Bown N; Haferlach T; Vandenberghe P; Haferlach C; Santibanez-Koref M; Moorman AV; Kohlmann A; Irving JA; Harrison CJ
    Leukemia; 2016 Sep; 30(9):1824-31. PubMed ID: 27168466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired uniparental isodisomies involving chromosome 12 in paediatric B-cell precursor acute lymphoblastic leukaemia: Associations with chromosome 21 gains and SH2B3 mutations.
    Lundin-Ström KB; Biloglav A; Castor A; Olsson-Arvidsson L; Johansson B
    Br J Haematol; 2023 May; 201(3):585-588. PubMed ID: 36899493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.